Skip to main content

Featured

Greek Tanker Struck by Missile in Black Sea, Crew Emerges Unharmed

  A Greek‑flagged tanker sailing near the Russian port of Novorossiysk was struck by a missile but remained operational, and all 24 crew members were confirmed safe.   A Greek‑owned and Greek‑flagged tanker sustained material damage after being hit by a missile while sailing approximately 14 nautical miles off the Russian port of Novorossiysk in the Black Sea. According to authorities, the vessel—operated by Maran Gas Maritime—was not carrying cargo at the time of the strike and continued to navigate safely following the incident.  All 24 crew members on board, including ten Greek nationals, thirteen Filipinos, and one Romanian, were reported to be in good health. The impact caused damage to the starboard side of the ship, but no assistance or towing was required. The tanker remained fully operational, and no environmental pollution was reported.  Greek officials have condemned the attack as dangerous and unacceptable, noting that the incident occurred amid height...
Post a Comment
Read more

article

Labels

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Labels:

Comments

Post a Comment